HMGB1 and Alzheimer disease: In addition, HMGB1 was proven to inhibit amyloid-β (Aβ) peptide clearance from the rat hippocampus by inhibiting microglial phagocytosis, thus potentiating Aβ-induced neurodegeneration in AD [11].